Natera (NTRA)
NASDAQ: NTRA · Diagnostics & Research · Austin, TX
Our rating: Neutral
Neutral reaffirmed at $288.48, moderate conviction, November 16, 2026.
Breaks if: On this Neutral call: we would turn Positive if revenue growth stays above 30% year-over-year and FCF margin breaks above 8% in the next two reported quarters — that would confirm operating leverage is arriving on schedule and that the valuation is being grown into. We would turn Cautious if revenue growth decelerates below 20% year-over-year or if free cash flow reverts to negative in either of the next two quarters, or if the November 13 patent invalidation expands to cover Natera's Signatera or Panorama platforms within the next twelve months.
Key figures
| Market value | $39.6B |
|---|---|
| Revenue, last 12 months | $2.9B |
| Net income, last 12 months | −$165M |
| Free cash flow, last 12 months | $52M |
| Price to earnings | n/a |
| Free cash flow yield | 0.1% |
| Dividend yield | 0.0% |
| Operating margin | −9.0% |
| Return on equity | −10.6% |
| Beta to the S&P 500 | 1.34 |
| Volatility, annualized | 48.0% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $794M | 34.1% | $-0.42 | $5M |
| June 30, 2026 | $753M | 37.7% | $-0.47 | −$9M |
| March 31, 2026 | $697M | 38.8% | $-0.60 | $18M |
| December 31, 2025 | $665M | 39.8% | $0.36 | $38M |
| September 30, 2025 | $592M | 34.7% | $-0.64 | $37M |
| June 30, 2025 | $547M | 32.2% | $-0.74 | $12M |
| March 31, 2025 | $502M | 36.5% | $-0.50 | $23M |
| December 31, 2024 | $476M | 53.0% | $-0.41 | $35M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $0.92B: Claude 38%, Gemini 40%, Mistral 58%
- Diluted earnings per share are at least $0.36: Claude 18%, Gemini 5%, Mistral 25%
- Free cash flow for the quarter is at least $0.04B: Claude 42%, Gemini 25%, Mistral 45%
23 ledger entries and 13 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.